Tadalafil
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
Sanjay Gandhi Postgraduate Institute of Medical Sciences
Overview
Tadalafil is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
Tadalafil clinical trials
Explore related
Medical disclaimer. This page summarizes research about Tadalafil for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.